Gufic Biosciences Limited — Updates, 13-03-2026: General Updates
13-03-2026 | 07:49 pm
13-03-2026 | 07:49 pm
Gufic Biosciences paid ₹1,80,000 in penalties for failing to secure shareholder approval for an independent director aged over 75. An appeal for waiver was rejected, finalizing the payment.
No comments yet. Be the first to comment!
